K163608 is an FDA 510(k) clearance for the HAART 300 Aortic Annuloplasty Device 19mm, HAART 300 Aortic Annuloplasty Devi.... Classified as Aortic Annuloplasty Ring (product code PST), Class II - Special Controls.
Submitted by Biostable Science & Engineering, Inc. (Austin, US). The FDA issued a Cleared decision on March 21, 2017 after a review of 90 days - within the typical 510(k) review window.
This device falls under the Cardiovascular FDA review panel, regulated under 21 CFR 870.3800 - the FDA cardiovascular device oversight framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.
Device pattern: Standard predicate-based submission. Standard predicate reliance. This clearance follows a standard predicate-based equivalence path within the Cardiovascular review framework, consistent with the majority of Class II 510(k) submissions.
NCT01400841
Completed
Interventional
Industry-sponsored
HAART Model 300 Annuloplasty Ring
A Prospective, Non-randomized, Multi-center Trial to Evaluate the Safety and Effectiveness of the HAART Model 300 Annuloplasty Ring When Used to Surgically Repair a Leaking Aortic Valve Using a 3-D Intra-annular Mounting Frame
| Condition studied |
Aortic Regurgitation |
| Study design |
Single group |
| Eligibility |
All sexes
· 50 Years+
|
| Principal investigator |
Christof Stamm, M.D. |
| Sponsor |
Biostable Science & Engineering
(industry)
|
Started 2012-01-01
→
Primary completion 2013-04-01
→
Completed 2014-09-01
Primary outcome
Primary Safety Outcome Measure: Event-free Survival
Secondary outcome
Implant Procedure Success
View full study on ClinicalTrials.gov